MedQuiry
PRELAUNCH · Q3 2026
Prelaunch · Q3 2026

A scoring standard
for medical research
credibility.

MedQuiry evaluates whether a published medical study is methodologically sound — over a hundred decision points across design, bias, statistics, and conflicts. Score one study in under five seconds.

100+
decision points / study
< 5s
median score time
0.0–10.0
MedQuiry score
Developed by physicians · Supported by AI · Audited by clinicians
Register · 1 free token

Score one study, on us.

Create a MedQuiry account to receive one free token. We will not ask for a credit card. Tokens never expire and are non-transferable.

Create account · Get free token

Already have an account? Sign in.

By creating an account you accept the Terms and Privacy Policy.

Sample report · static preview
Randomized controlled trial · n = 412
Low‑Dose Naltrexone for Chronic Fatigue Syndrome: A 16‑Week Double‑Blind Trial
Lancet Rheumatology · 2025 · doi:10.1016/lr.2025.0211
Strong designPre‑registeredIndustry‑independent
8.2
Score explanation
Pre‑registered protocol with adequate randomization and blinding. Modest sample size; per‑protocol analysis reduces external validity. No declared conflicts.